Rationale: Differential effects of ␦ B and ␦ C subtypes of Ca 2؉ /calmodulin-dependent protein kinase (CaMKII) on cardiomyocyte Ca 2؉ handling and survival have been suggested to result from their respective nuclear versus cytosolic localizations. CaMKII␦ subtype localization and its relationship to enzyme activation and target phosphorylation have not, however, been systematically evaluated.
C a 2ϩ /calmodulin-dependent protein kinase II (CaMKII) is a multifunctional serine/threonine kinase critical for Ca 2ϩ signaling in cardiomyocytes. Our work and that of others has implicated CaMKII in the development of cardiac hypertrophy and heart failure (HF). [1] [2] [3] [4] [5] [6] [7] The expression of CaMKII is elevated in animal HF models and human HF patients. 1, 2 Transgenic overexpression of the predominant cardiac isoform CaMKII␦ elicits hypertrophy and HF, whereas genetic deletion or inhibition of CaMKII␦ prevents HF development. [3] [4] [5] [6] [7] Two splice variants, CaMKII␦ B and ␦ C, are known to be present in cardiac myocytes. 8 The CaMKII␦ B and ␦ C subtypes have been implicated in distinct cardiomyocyte functions, 2 but the exclusivity of their localization, potential selectivity in activation mechanisms, and relationship of localization and subtype to functional outcomes have not been well defined.
CaMKII is activated by Ca 2ϩ /calmodulin binding to the enzyme. The resultant conformational change favors subsequent autophosphorylation of the enzyme to a Ca 2ϩ -independent activated form. 9 Oxidation can also lead to CaMKII activation. 10 Downstream targets phosphorylated by CaMKII␦ include proteins important for the modulation of Ca 2ϩ handling such as phospholamban (PLN), ryanodine receptors (RyR2), voltage sensitive L-type Ca 2ϩ channels, and the Na v 1.5 Na ϩ channel subunit 1, 2, [11] [12] [13] [14] CaMKII␦ can also regulate gene transcription, for example, by phosphorylation of type II histone deacetylases (HDACs), which derepress myocyte enhancer factor-2 (MEF2), [15] [16] [17] or through AP-1 18, 19 or GATA4. 20 CaMKII␦ B and ␦ C subtypes differ only by the presence of an 11-amino acid nuclear localization sequence (NLS) in CaMKII␦ B. 8, 21 The Schulman laboratory established and we subsequently confirmed that heterologously expressed CaMKII␦ B primarily localizes to the nucleus, whereas ␦ C is found primarily in the cytosol. 8, 21, 22 Accordingly, we postulated different functions of the 2 subtypes, with nuclear ␦ B involved in hypertrophic gene regulation and cytosolic ␦ C in the regulation of Ca 2ϩ handling and ion channels. This was supported by early findings using isolated neonatal rat ventricular myocytes [23] [24] [25] [26] [27] [28] [29] [30] and by the differential phenotypes that we observed in the CaMKII ␦ B and ␦ C transgenic (TG) mice models. 3, 4, 11, 22, 31 More specifically, CaMKII␦ B TG mice primarily develop cardiac hypertrophy whereas hypertrophy in the ␦ C TG mice rapidly transitions to HF characterized by severely disrupted cytosolic Ca 2ϩ handling. 3, 32 Subsequent work directly comparing the 2 lines showed that ␦ B and ␦ C both modulate MEF2 activity and gene expression, a result attributed to the ability of CaMKII␦ to phosphorylate HDAC in either the cytosol or the nucleus. 32 In the studies presented in the present report, we more extensively investigate the localization of CaMKII␦ B and ␦ C subtypes in the mouse heart ventricle and isolated cardiomyocytes. We further test the hypothesis that enzyme location within the myocyte determines its activation by stimuli that mobilize distinct subcellular pools of Ca 2ϩ .
The findings reported here demonstrate that CaMKII ␦ B is indeed concentrated in the nucleus and CaMKII ␦ C at the sarcoplasmic reticulum (SR) but that this localization is not exclusive, either for the endogenous or overexpressed enzyme. Additionally, we report that the nature of the stimulus and presumed site of localized Ca 2ϩ release determines where CaMKII is activated and is indiscriminate with regard to enzyme subtype. Finally, we show that downstream target phosphorylation provides a functional readout of the consequences of activation of CaMKII at specific cellular locations.
Methods
An expanded Methods section is available in the Data Supplement at http://circres.ahajournals.org. Subcellular fractionation of mouse ventricle was performed by differential centrifugation using minor modifications of a published procedure. 33 To compare expression levels in different subcellular compartments, equal portions (eg, 50%, 100%) of each fraction were loaded onto SDS gels and analyzed by immunoblotting. Distribution of green fluorescent protein (GFP)-tagged CaMKII ␦ B and ␦ C in adult mouse ventricular myocytes (AMVM) was visualized by confocal microscopy after adenoviral overexpression. Isolated hearts were perfused in the Langendorff mode 34 and treated with vehicle, phenylephrine (PE) or caffeine. AMVMs were isolated from wild type and knockout as described. 35 CaMKII activation was assessed by Western blotting using a P-CaMKII antibody from Affinity Bioreagents. 4 All procedures were performed in accordance with NIH Guide for the Care and Use of Laboratory Animals and approved by the Institutional Animal Care and Use Committee. Results are reported as averages ϮSEM. Statistical significance was determined using ANOVA followed by the Tukey post hoc test. PϽ0.01 was considered statistically significant. For additional details regarding the methods used, see the Online Supplemental Material.
Results
Ventricular tissue and AMVMs isolated from adult wild-type (WT) and CaMKII␦ knockout (␦KO) mice were analyzed by Western blotting using a CaMKII␦ antibody that recognizes both CaMKII␦ B and ␦ C . Two bands were clearly evident in the WT and absent in the CaMKII␦ KO mouse heart ( Figure  1A) . The difference in mobility of these bands is consistent with the inclusion of an 11-amino acid (2 kDa) NLS in CaMKII␦ B . 8, 21 Quantification of the individual bands indicates that CaMKII␦ B is the more predominant splice variant, with approximately 60% of the total endogenous CaMKII migrating as the ␦ B subtype, and just under 40% as ␦ C ( Figure 1B ). To determine which subcellular compartments contain endogenous CaMKII␦ isolated left ventricle was fractionated into cytosolic (Cyto), mitochondrial (Mito), SR/membrane (SR/mem), and nuclear (Nuc) fractions. The purity of these fractions was verified using the markers Rho GDP-dissociation inhibitor (Rho-GDI), voltage-dependent anion channel (VDAC), sarcoplasmic reticulum Ca 2ϩ ATPase (SERCA2a)and Lamin A/C, respectively ( Figure 2A ). To compare CaMKII protein expression among these fractions, the entire volume of each fraction was loaded onto SDS gels. Immunoblotting for CaMKII␦ revealed that there were nearly equivalent amounts of CaMKII␦ in the SR/membrane and nuclear compartments of the cell (together accounting for approximately 75% of the total enzyme), whereas less than 20% was in the cytosolic fraction and a smaller percentage was associated with the mitochondrial fraction ( Figure 2B ). The subtype composition of CaMKII␦ in each subcellular fraction was then analyzed by separately quantifying the individual ␦ B and ␦ C bands, as seen in Figure 3A . This analysis revealed that both subtypes were present in every compartment examined ( Figure 3B ). Importantly, CaMKII␦ B was detected not only in the nuclear compartment, but also in the SR/membrane compartment; conversely CaMKII␦ C , though abundant in the SR/membrane, was also clearly present in the nuclear compartment ( Figure 3B ). We have generated cardiac-specific CaMKII␦ B and ␦ C TG mice and characterized these lines in numerous studies. 3, 4, 31, 32 We assumed that the phenotypic differences observed in these TG lines correlated with differential increases in expression of ␦ B and ␦ C in the nuclear versus SR compartments, respectively. To reevaluate this assumption in light of our findings on the distribution of endogenous CaMKII subtypes, we isolated and fractionated ventricular tissue from CaMKII␦ B and ␦ C TG mice. As in the experiments above, the entire volume of each fraction was loaded onto SDS gels to compare CaMKII protein expression among these fractions (Online Figure I) . The percentage of the total CaMKII␦ transgene in each subcellular compartment was quantified and the data from a series of experiments averaged and shown in Figure 4A . Remarkably, whereas CaMKII␦ B TG mice show a high concentration of CaMKII␦ B in cardiomyocyte nuclei, based on immunofluorescence staining, 32 subcellular fractionation indicates that significant amounts of CaMKII␦ B are also present outside of the nucleus in the cytosolic and SR/membrane fractions ( Figure 4A ). In the CaMKII␦ C TG mice, immunostaining revealed relative exclusion of CaMKII␦ C from the nucleus, 32 but, whereas most CaMKII␦ C is in the SR/membrane fraction, the CaMKII␦ C subtype is clearly detectable in the nuclear fraction as well ( Figure 4A ). Thus distribution of the transgenes, like that of endogenous CaMKII␦ subtypes, is not exclusive.
CaMKII␦ is believed to exist as a multimer of 12 subunits. 9 Nuclear versus cytosolic localization can be significantly affected by changing the expression ratio of ␦ B and ␦ C splice variants, consistent with heteromultimerization of these subtypes. 3622,37 ⌴ultimerization of transgenically expressed CaMKII␦ C with endogenous CaMKII␦ B could promote its localization to the nucleus, whereas multimerization of CaMKII␦ B with endogenous CaMKII␦ C could lead to its exclusion from the nuclear compartment. To test the hypothesis that the broad and relatively nonselective subcellular distribution of the CaMKII ␦ B and ␦ C subtypes results from their heteromultimerization, we crossed the CaMKII␦ B and ␦ C TG mice with the CaMKII␦ KO mice previously developed in our laboratory. Progeny from these crosses were shown to express only a single CaMKII␦ subtype (␦ B or ␦ C ) in the CaMKII␦ null background. Interestingly, the subcellular distribution of the CaMKII␦ C and ␦ B transgenes expressed in the CaMKII␦ null background ( Figure 4B ) was not appreciably different from that of the ␦ B and ␦ C transgenes expressed in the WT background ( Figure 4A ).
To examine the distribution of the ␦ B and ␦ C subtypes in a manner that does not require cell disruption and fractionation we infected AMVMs from ␦KO mice with GFP-tagged CaMKII ␦ B and ␦ C adenovirus. Myocytes infected with CaMKII␦ B and visualized by confocal microscopy clearly showed accumulation of the overexpressed protein in the nuclear compartment, but a significant amount of CaMKII␦ B was also seen outside the nucleus, distributed in a striated pattern corresponding to T-tubule organization ( Figure 5A ). Line scan quantification of fluorescent intensity of a 1-m-thick plane from several different cells showed the fluorescence intensity of CaMKII␦ B in the nucleus to be 2.69 (Ϯ0.08) times higher than that of CaMKII␦ B in the cytosol; expressed another way, CaMKII ␦ B fluorescence intensity outside of the nuclear compartment is approximately one-third that in the nucleus. Experiments were also carried out using GFP-tagged CaMKII␦ C , and showed prominent localization coincident with the striated patterns of the cardiomyocyte ( Figure 5B ). Significant perinuclear CaMKII␦ C staining was also observed. Line scan quantification of CaMKII␦ C fluorescence intensity showed the nuclear ␦ C signal to be 0.44 (Ϯ0.09) of that in the extranuclear compartment; expressed another way the fluorescence intensity of CaMKII␦ C inside the nuclear compartment is approximately half of that in the cytosol.
Many of the functional effects of CaMKII in the myocardium, in particular those ascribed to CaMKII␦ C , result from phosphorylation of SR targets involved in Ca 2ϩ handling. Because the SR/membrane fraction obtained from the protocol used in the Figures 2-4 is heterogeneous (eg, it includes sarcolemmal membranes), we optimized a sucrose density gradient separation . AMVMs were imaged using confocal microscopy, DAPI staining was used to identify the nuclei, and line scan quantification was used to measure fluorescence intensity and determine enzyme distribution. Scale bar is 15 m. Background measurements taken from noninfected AMVMs were averaged and subtracted from the fluorescence intensity measurements of the GFP-tagged enzyme.
protocol to isolate a more purified SR fraction. We looked at purity of the SR and nuclear fractions by immunoblotting using markers for cytosol, mitochondria, SR, and nucleus and found the SR ( Figure 6A ) and nuclear ( Figure 6B ) fractions to contain some mitochondria (VDAC staining) but otherwise show little cross contamination. Immunoblots from the purified SR and nuclear fractions show 2 CaMKII␦ bands ( Figure 6C and 6D) . Whereas the lower band, CaMKII␦ C , is the more abundant in the SR ( Figure 6C ), and CaMKII␦ B is predominant in the nuclear fraction ( Figure 6D ), the 2 subtypes are clearly not exclusively segregated to a specific compartment.
The finding that CaMKII ␦ B and ␦ C subtypes colocalize in the same subcellular compartment suggested that they could also be activated in parallel. To determine whether this is the case, we isolated hearts from WT mice, perfused them in the Langendorff mode and then either treated them with a bolus injection of 10 mmol/L caffeine (to release SR Ca 2ϩ ) or perfused them for 15 minutes with 100 nmol/L PE (to increase nuclear Ca 2ϩ levels). 17, 38 Hearts were then fractionated to obtain purified SR and nuclei (as described in Figure 6 ) and analyzed by Western blot analysis. Phosphorylation of CaMKII at Thr286, the site of enzyme autophosphorylation, was used as a read-out for CaMKII activation. Perfusion with caffeine increased P-CaMKII in the SR fraction but not in the nuclear fraction ( Figure 7A ). In contrast, PE treatment increased P-CaMKII levels in the nuclear fraction but not in the SR fraction ( Figure  7A ). Because the resolution of the P-CaMKII antibody is not adequate to individually distinguish the endogenously expressed phosphorylated CaMKII␦ B and CaMKII␦ C subtypes, we repeated these experiments using the ␦ B and ␦ C TG mice (in the CaMKII␦ null background). The data shown in Figure 7B and 7C demonstrate that caffeine significantly increases phosphorylation of both CaMKII␦ B and CaMKII␦ C in the SR (but not in the nuclear fraction). In contrast PE treatment elicits 2-to 3-fold increases in phosphorylation of both CaMKII␦ B and CaMKII␦ C in the nuclear fraction but not in the SR. Thus caffeine selectively activates whichever CaMKII␦ subtype is located at the SR but not that located in the nucleus, whereas PE selectively activates whichever CaMKII subtype is localized to the nucleus.
The experimental findings cited above suggest that CaMKII␦ B or CaMKII␦ C can be activated by the same agonists and could subserve similar functions. We examined functional consequences of compartmentalized CaMKII activation by measuring the phosphorylation of established CaMKII phosphorylation sites on 2 CaMKII targets, PLN localized to the SR and HDAC5, largely localized to the nucleus. Perfused hearts were treated with PE or caffeine using the same protocol used to examine CaMKII activation and homogenized for analysis of CaMKII substrate phosphorylation. In WT mice (Figure 8 ) or CaMKII␦ B TG (Online Figure II) , treatment with caffeine lead to significant increases in phosphorylation of PLN at Thr17 while treatment with PE did not lead to PLN phosphorylation ( Figure 8A ). Conversely, treatment with PE increased phosphorylation of HDAC5 at Ser498, whereas caffeine did not increase phosphorylation ( Figure 8B ). Concomitant perfusion with KN-93, a CaMKII inhibitor, prevented caffeine induced phosphorylation of PLN Thr17 and PE induced phosphorylation of HDAC5 at Ser498 (Online Figure III) . Additionally, we observed no increase in phosphorylation of these substrates at their putative CaMKII phosphorylation sites in CaMKII␦ KO mice treated with caffeine or PE ( Figure IV ). These data demonstrate that PLN Thr17 and HDAC5 Ser498 are CaMKII phosphorylation sites and that there is specificity in the effects of caffeine and PE on CaMKII mediated phosphorylation of these substrates. 
Discussion
CaMKII␦ B and ␦ C subtypes, which differ only by the inclusion of a nuclear localization sequence, are present in the mouse heart ventricle at similar protein levels (Figure 1 ). Seminal papers from the Schulman laboratory describing these 2 splice variants, 8, 21 along with our early studies in which we expressed CaMKII␦ B and ␦ C in neonatal rat ventricular myocytes (NRVMs), 22 supported the notion that CaMKII␦ B would be localized to and signal in the nucleus, whereas ␦ C would localize to and signal outside of the nucleus. These conclusions were based on studies in which CaMKII␦ was heterologously expressed in COS cells or NRVMs. 22, 39, 40 Subsequently, we generated CaMKII␦ B or ␦ C TG mice and examined the HA-tagged protein by immunostaining of myocytes isolated from these mice. 3, 4, 32 Our findings were consistent with the predominant localization of CaMKII␦ B in the nucleus and ␦ C in the cytosol. 3, 4, 32 The concept that nuclear and cytosolic splice variants/subtypes subserved different functions was supported by the distinct phenotypes that we observed in the CaMKII␦ B and ␦ C TG mice. We recognized that the pathological changes seen in these mouse models could be exaggerated by overexpression but reasoned that this approach emphasized the compartment specific effects of the 2 subtypes: nuclear effects on gene expression leading to hypertrophy in the CaMKII␦ B TG mice, and effects on SR protein phosphorylation and Ca 2ϩ handling leading to HF development in the CaMKII␦ C TGs.
The more extensive analysis presented in the current manuscript was motivated by our observation that endogenous CaMKII␦ is found in both the SR/membrane and nuclear compartments isolated from mouse ventricle and that there are 2 CaMKII␦ immunoreactive bands in both of these compartments ( Figures 3A and 6 ). That these bands are absent in CaMKII␦ knockout mouse hearts ( Figure 1A ) indicates that they are both CaMKII␦ gene products, whereas the fact that they differ in mobility by approximately 2 kDa suggests that they represent ␦ C and the 11 amino acid larger NLS containing ␦ B . 21 The ability of various CaMKII isoforms and subtypes to form heteromultimers 9,36 provides a feasible explanation for the appearance of either subtype in the nucleus (or SR) independent of whether it possesses an NLS. Remarkably, however, the expression of CaMKII␦ B in the absence of CaMKII␦ C did not restrict its localization to the nucleus nor was ␦ C confined to the cytosolic/SR compartment when expressed in the absence of ␦ B ( Figure 4B ). Thus heteromultimers of CaMKII␦ B and ␦ C appear unlikely to account for the indiscriminate distribution of these subtypes. We cannot rule out the possibility that other minor cardiac CaMKII isoforms, including CaMKII␥ and ␤, heteromultimerize with CaMKII␦ and contribute to its appearance in unexpected locations, although this seems quantitatively unlikely. Regardless of the molecular mechanism, the conclusion from our subcellular fractionation experiments is that CaMKII␦ B is not restricted to the nuclear compartment, and ␦ C is not excluded from the nuclear compartment.
Because subcellular fractionation does not yield complete separation of organelles and also can disrupt normal structure we extended our studies using confocal microscopy of intact AMVMs infected with GFP-tagged CaMKII␦ B or ␦ C . Data obtained by confocal imaging shows extensive accumulation of GFP-tagged CaMKII␦ B in the nucleus, consistent with what we reported previously. 32 Notably however, quantitative analysis confirmed that ␦ B is not wholly restricted to the nucleus; indeed ␦ B fluorescence intensity outside of the nuclear compartment was approximately one-third that in the nucleus. The intensity of the nuclear staining is indeed striking but this reflects, in part, the fact that the enzyme is concentrated in a very small compartment. The distribution of GFP-tagged CaMKII␦ C appeared largely consistent with the earlier studies from our laboratory suggesting that ␦ C is excluded from the nucleus. However, quantitative analysis showed that the fluorescence intensity inside the nuclear compartment was not zero but was approximately half of that in the cytosol. Of additional note, our assessment of CaMKII␦ C nuclear fluorescence intensity does not include what appears to be a prominent pool of GFP-tagged perinuclear CaMKII␦ C ; whether this represents mitochondria, SR, or other cellular organelles in confluence with the nucleus, this compartment of CaMKII␦ C probably would be included in our nuclear fractionation and thus contribute to higher estimates for the proportion of nuclear CaMKII␦ C in the fractionation experiments. Finally, it should be noted that the insoluble fraction discarded in the low-speed spin of the fractionation protocol would contain some of the total cellular CaMKII␦, thus the percent of total calculated for each fraction is somewhat inflated. Regardless of the limitations inherent in the use of either the adenoviral overexpression or subcellular fractionation experiments, and independent of judgment as to which approach give the most valid estimate of CaMKII␦ B and ␦ C in each compartment, all of the preparations and approaches utilized here lead us to the same conclusions: the CaMKII␦ B and CaMKII␦ C isoforms are not restricted to specific subcellular locations.
The finding that both CaMKII subtypes are present throughout the cell raised the question of whether localization or subtype would determine when and how the enzyme was activated. We used interventions expected to mobilize Ca 2ϩ from distinct cellular locations to examine CaMKII␦ activation in WT mouse hearts. This was supplemented with studies using hearts from the subtype-specific transgenics to facilitate analysis of the activation of individual subtypes. Our findings clearly demonstrated that PE increases phosphorylation of CaMKII␦ B or ␦ C in the nuclear compartment with little change in activation of either subtype at the SR; conversely, caffeine activates both CaMKII␦ B and ␦ C in the SR, with little change in activation of either subtype in the nuclear compartment ( Figure 7 ). Several published studies have highlighted the importance of localized Ca 2ϩ stores and subsequent compartmentalized signaling within the cardiomyocyte. [41] [42] [43] In cardiomyocytes, the majority of inositol trisphosphate receptors (IP 3 R 2 ) are located on the nuclear envelope and our previous work demonstrated that endothelin-1 and PE increase Ca 2ϩ release from nuclear IP 3 sensitive stores. 17,38 Thus we believe that the selectivity of PE for inducing nuclear CaMKII activation reflects Ca 2ϩ mobilization through IP 3 sensitive stores in or around the nucleus, although other similarly localized signaling pathways cannot be ruled out. Treatment with caffeine would instead be expected to cause a large [Ca] i increase in the cleft region as a result of SR Ca 2ϩ mobilization, consistent with CaMKII activation at the SR. Thus the studies presented here demonstrate for the first time that there is compartmentalized activation of CaMKII␦, with the cellular compartment determined by the stimulus and presumed site of Ca 2ϩ release, and notably independent of subtype. The functional relevance of compartmentalized CaMKII␦ activation was demonstrated by studies in which we examined substrate phosphorylation. Phosphorylation of the SR target, phospholamban at its well-documented CaMKII-specific phosphorylation site, 5, 44, 45 was confirmed here (Online Figures III  and IV ) and shown to be selectively increased after addition of caffeine ( Figure 8 ). Phosphorylation of the nuclear transcriptional regulator HDAC5 at a site indicated by previous studies and in Online Figures III and IV to be a CaMKII phosphorylation site 17, 46, 47 was selectively increased after PE treatment (Figure 8 ). Agonist selectivity in substrate phosphorylation was demonstrated in studies using both WT (Figure 8 ) and CaMKII␦ B TG (Online Figure II) mice. The high basal level of PLN and HDAC phosphorylation seen in the CaMKII␦ C TG heart (Online Figure II) precluded detection of further agonist Figure 8 . Caffeine preferentially increases phospholamban phosphorylation and PE preferentially increases HDAC5 phosphorylation in mouse heart. Hearts were isolated from mice perfused with 10mmol/L caffeine or 100 nmol/L phenylephrine. Ventricular homogenate was subjected to Western blotting for A, PLN phosphorylation at the CaMKII phosphorylation site, threonine-17; and B, HDAC5 phosphorylation using an antibody for the CaMKIIspecific epitope. Quantified data are from nϭ5. *PϽ0.01.
induced increases, although it does indicate that both of these substrates are in vivo targets for CaMKII␦ C . Notably our previous analysis of the CaMKII ␦ C TG mouse heart demonstrated increased PLN and RyR2 phosphorylation associated with dysfunctional Ca 2ϩ handling and heart failure phenotype. 3, 32 The reason that we did not see RyR2 and PLN phosphorylation and Ca 2ϩ handling changes in the CaMKII␦ B TG mice 32 may be that the level of CaMKII transgene expression is lower in the SR of the CaMKII ␦ B TG mice than in the SR of CaMKII ␦ C TG mice (Online Figure V) . We do find, however, that both PLN and RyR2 are highly phosphorylated in neonatal rat cardiomyocytes after adenoviral expression of equal levels of either CaMKII ␦ B or CaMKII ␦ C (data not shown), supporting the notion that either subtype can phosphorylate these SR targets.
In conclusion, we demonstrate for the first time that CaMKII␦ B and ␦ C subtypes are not exclusively localized. We also present evidence that both subtypes can be activated at the same cellular locations and that the activation is stimulus and location dependent rather than subtype dependent. Phosphorylation of different CaMKII␦ substrates is also dependent on the nature of the stimulus. The evidence for nonselective CaMKII␦ subtype localization is particularly interesting and challenging with regard to understanding mechanisms by which CaMKII␦ B could subserve a protective role, and ␦ C a more deleterious role in cardiomyocyte survival and heart disease. 12, 48, 49 
Novelty and Significance
What Is Known?
• Ca 2ϩ /CaM kinase II regulates cardiac Ca 2ϩ handling and plays a critical role in adverse cardiac remodeling in response to pressure overload, catecholamines, and ischemic stress.
• CaMKII delta (CaMKII␦) is the predominant cardiac isoform and is present as 2 major splice variants (subtypes): CaMKII␦ B , which contains a nuclear localization sequence, and CaMKII␦ C , which does not contain a nuclear localization sequence.
• Based on cellular or transgenic overexpression, the 2 subtypes are differentially localized and accordingly serve different functions: CaMKII␦ B regulates gene expression and cell survival whereas CaMKII␦ C regulates Ca 2ϩ handling and cell death.
What New Information Does This Article Contribute?
• The 2 CaMKII␦ subtypes are not as exclusively localized as previously believed: the SR compartment contains considerable amounts of CaMKII␦ B and the nuclear compartment contains significant amounts of CaMKII␦ C .
• Two Ca 2ϩ mobilizing agonists, caffeine and phenylephrine, differentially activate CaMKII␦ in accordance with enzyme localization (caffeine in SR, phenylephrine in nucleus) and increase substrate phosphorylation (phospholamban and HDAC-5), independent of CaMKII␦ subtype.
• Specificity in CaMKII␦ signaling results from compartmentalized, rather than subtype specific, activation.
This study was designed to test the concept that CaMKII␦ B and CaMKII␦ C , the 2 predominant cardiac splice variants (subtypes) of CaMKII, serve different functions due to their distinct localizations. Surprisingly, subcellular fractionation studies revealed that all fractions examined, including mitochondria, SR/membrane and nucleus contained a mixture of the 2 subtypes. Using hearts from mice in which only one of the 2 subtypes was expressed (␦ B or ␦ C transgenic mice in a CaMKII␦ knockout background), we show that this is not a result of heteromultimerization of the subtypes. We then asked whether the subtypes, if not distinctly localized, were differentially regulated. Two agonists that mobilized Ca 2ϩ , caffeine, and phenylephrine, were shown to activate both CaMKII␦ B and ␦ C . Strikingly, regardless of subtype, caffeine activated CaMKII␦ in the SR compartment and increased phosphorylation of the SR CaMKII substrate, phospholamban, whereas phenylephrine only activated CaMKII␦ in the nucleus and increased phosphorylation of the nuclear CaMKII target, HDAC-5. These findings question the accepted notion of strict "nuclear" versus "cytoplasmic" isoforms of CaMKII␦, while demonstrating that there is compartmentalized activation of CaMKII␦ and its functional targets in cardiomyocytes.
